"This collaboration with Mayo Clinic is a great opportunity for IM8," said Shengwu Yang, CEO of Prenetics. "Together, we are developing supplements that are not only based on rigorous scientific evidence, but also provide real health benefits. The project is progressing well, and the initial research results are very encouraging. We are excited about the future."
Dr. Dawn Mussallem, an integrative oncologist at Mayo Clinic and a member of IM8's scientific advisory board, will be involved in providing professional advice to help design precise and scientifically rigorous supplements to meet the diverse health needs of modern people.
Mayo Clinic has a financial interest in the technology mentioned in this greece phone number list news release, and proceeds from the technology support its nonprofit mission to advance patient care, education and research.
Prenetics is a leading health sciences company driving innovation in consumer and clinical health. Our consumer business is led by two major brands: IM8 and Europa. IM8 is our new health brand; and Europa is the top sports nutrition distributor in the United States. The clinical business is led by Insighta, which focuses on early detection technologies for multiple cancers, and the transaction is valued at $200 million.